Lorazepam Vs. Alprazolam in the Treatment of Panic Disorder
The DOI matches its Crossref record.
Abstract
Sixty-seven patients with panic disorder were treated with single-blind placebo for one week before being randomized to 6 weeks of double-blind treatment with either lorazepam or alprazolam. Both drugs showed significant and comparable antipanic efficacy throughout the course of the study. With the exception of sedative effects, both drugs were well-tolerated at a mean daily dose of 7 mg for lorazepam and 3 mg for alprazolam. Lorazepam appeared to be as effective as alprazolam in the acute treatment of panic disorder. Zusammenfassung 67 Patienten mit Panikzuständen und angstneurotischen Störungen mit Panikanfällen wurden mit Einfachblind-Plazebo eine Woche lang behandelt, ehe sie einer 6wöchigen randomisierten Doppelblindbehandlung mit Lorazepam bzw. Alprazolam unterzogen wurden. Beide Präparate zeigten eine signifikante und vergleichbare antipanische Wirkung während des gesamten Verlaufs der Studie. Mit Ausnahme der sedativen Wirkungen wurden beide Präparate gut toleriert, wobei die mittlere Tagesdosis 7 mg bei Lorazepam und 3 mg bei Alprazolam betrug. Lorazepam schien ebenso wirksam wie Alprazolam in der akuten Behandlung panischer Zustände und Störungen zu sein.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
Bandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802465807 · Cited by 854
Can interoception improve the pragmatic search for biomarkers in psychiatry?
Khalsa, S. S., & Lapidus, R. C. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00121 · Cited by 366
Treatment-Resistant Panic Disorder
Bandelow, B., & Rüther, E. (2004) · CNS Spectrums · doi:10.1017/s1092852900022379 · Cited by 57
Benzodiazepines and anxiety disorders: a review for the practicing physician
Kaplan, E. M., & DuPont, R. L. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x48401 · Cited by 55
Metadata
- Authors
- Schweizer, E., Pohl, R., Balon, R., Fox, I., Rickels, K., & Yeragani, V.
- Venue
- Pharmacopsychiatry
- Publisher
- Georg Thieme Verlag KG
- Published
- 1990-03
- Volume
- 23
- Issue
- 02
- Pages
- 90-93
- ISSN
- 0176-3679 (ISSN-L)
- 1439-0795
- OpenAlex
- W2114790709
- Cited by
- 58
- References
- 0
- FWCI
- 3.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lorazepam Vs. Alprazolam in the Treatment of Panic Disorder. https://app.cochat.ai/papers/10.1055/s-2007-1014489
- The paper
- Schweizer, E., Pohl, R., Balon, R., Fox, I., Rickels, K., & Yeragani, V. (1990). Lorazepam Vs. Alprazolam in the Treatment of Panic Disorder. Pharmacopsychiatry. https://doi.org/10.1055/s-2007-1014489
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.